Fundraising FoxLigand Pharmaceuticals — Full Portfolio
5 tracked investments · listed companies and verified rows first
Agenus is a biotechnology company developing cancer immunotherapies, including its lead investigational combination of botensilimab (an anti-CTLA-4 antibody) and balstilimab (a PD-1 inhibitor), known as BOT+BAL.
BiotechHealthtechLexington, US
Garo Armen(Chairman & CEO, Co-founder)Ozer Baysal(Executive Officer)Robert Stein(Executive Officer)Christine Klaskin(Executive Officer)inKaren Valentine(Executive Officer)Steven O'Day(Chief Medical Officer)in
Co-investorsAdvent Life SciencesGrazia Equity GmbHHEALTHCARE ROYALTY PARTNERSOberland CapitalCommodore CapitalInvus+1 more
Travere Therapeutics develops and delivers therapies for rare kidney and metabolic diseases, with a pipeline including potential first-in-class treatments for conditions such as classical homocystinuria and immune-mediated rare kidney diseases.
BiotechDigital HealthHealthtechMedical Devices
Eric Dube(Chief Executive Officer and Director)in
Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders.
BiotechHealthtechLongevitySan Diego, US
Brian Lian(President, CEO & Director (Founder))inMichael Morneau(Chief Financial Officer)Dr. Lian(President & Chief Executive Officer, Director)Stephen W. Webster(Director)Matthew W. Foehr(Director)
BoardJ. Matthew Singleton(Director)
Co-investorsAvoro Capital Advisors
A biotechnology company developing new therapies for patients with high unmet medical needs.
Biotech
Co-investorsDolby Family VenturesLifeSci Venture PartnersSofinnova VenturesThe W FundCommodore CapitalFranklin Templeton+5 more
Zerion is a self-custodial, multichain wallet and data platform that aggregates assets and positions across 58+ blockchains in real time, offering swap routing, trading, and an API for wallet data access.
Crypto & Web3Data & InfrastructureFintechSan Francisco, US
Evgeny Yurtaev(Founder & CEO)inAlex Bashlykov(Director)in
BoardToby Coppel(Director)inVadim Koleoshkin(Director)inBrad Burnham(Director)in
Co-investorsAlliance DAO (ex DeFi Alliance)BitDAOBlockchain CoinvestorsDe Fi Alliance HoldingsDigital Currency GroupG1 Ventures+18 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
XOMA Royalty
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.